T-CELLS AND MONOCYTES REGULATE THE GENERATION AND FUNCTIONAL-ACTIVITY OF NATURAL KILLER-DERIVED LYMPHOKINE-ACTIVATED KILLER-CELLS

被引:1
|
作者
ATZPODIEN, J [1 ]
GULATI, SC [1 ]
机构
[1] MEM SLOAN KETTERING CANC CTR, DEPT MED, NEW YORK, NY 10021 USA
关键词
LAK CELLS; NK REGULATION; T-CELLS;
D O I
10.1002/stem.5530110620
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The lymphokine-activated killer (LAK) phenomenon is generally referred to as nonspecific, i.e., major histocompatibility complex (MHC)-unrestricted cytotoxicity against tumor cells generated by ex vivo culture of human peripheral blood lymphocytes with interleukin 2 (IL-2). In this study, we selectively purified and depleted cell subpopulations such as natural killer (NK) cells, T-lymphocytes and monocytes from fresh human peripheral blood by negative selection. While highly purified NK cells could be induced to acquire potent LAK activity in five-day culture with IL-2, the presence of T-lymphocytes and monocytes in NK cultures was needed in order to induce a significant expansion of cytotoxic effector cells over the culture period. Neither T cells nor monocytes by themselves were able to generate LAK cells in a standard rive-day IL-2 culture. However, when added to highly purified NK cells prior to IL-2 incubation, a proportion of CD3, T-lymphocytes was found to gain LAK-like killing activity. Monocytes, when cultured with IL-2 in the presence of NK cells and T-lymphocytes, did not appear to acquire LAK activity but were able to induce a dramatic increase in cytotoxic lymphocyte recovery after five days with IL-2. In summary, we could demonstrate that peripheral blood T-lymphocytes and monocytes are potent regulators of NK-dependent lymphokine (IL-2)-activated killing.
引用
收藏
页码:511 / 518
页数:8
相关论文
共 50 条
  • [41] SUBCELLULAR-LOCALIZATION OF PERFORIN AND SERINE ESTERASE IN LYMPHOKINE-ACTIVATED KILLER-CELLS AND CYTOTOXIC T-CELLS BY IMMUNOGOLD LABELING
    OJCIUS, DM
    ZHENG, LM
    SPHICAS, EC
    ZYCHLINSKY, A
    YOUNG, JDE
    JOURNAL OF IMMUNOLOGY, 1991, 146 (12): : 4427 - 4432
  • [42] MORPHOLOGIC AND FUNCTIONAL-CHARACTERIZATION OF PERFORIN-DEFICIENT LYMPHOKINE-ACTIVATED KILLER-CELLS
    LIU, CC
    WALSH, CM
    ETO, N
    CLARK, WR
    YOUNG, JDE
    JOURNAL OF IMMUNOLOGY, 1995, 155 (02): : 602 - 608
  • [43] HUMAN LYMPHOKINE-ACTIVATED KILLER-CELLS (LAK CELLS) AS A POTENTIAL IMMUNOTHERAPEUTIC MODALITY
    GRIMM, EA
    BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 865 (03) : 267 - 279
  • [44] EFFECTS OF SURGERY ON THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS IN PATIENTS WITH BREAST-CANCER
    MCCULLOCH, PG
    MACINTYRE, A
    BRITISH JOURNAL OF SURGERY, 1993, 80 (08) : 1005 - 1007
  • [45] A FUNCTIONAL AND PHENOTYPIC COMPARISON OF MURINE NATURAL-KILLER (NK) CELLS AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    HOSKIN, DW
    STANKOVA, J
    ANDERSON, SK
    RODER, JC
    INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (05) : 940 - 948
  • [46] IMMUNOREGULATION OF LYMPHOKINE-ACTIVATED KILLER CELLS
    NAIR, MPN
    SCHWARTZ, SA
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 49 (01): : 28 - 40
  • [47] PREVENTION OF INVIVO ALLOREACTIONS BY ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER-CELLS
    KAPLAN, J
    UBERTI, J
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1991, 636 : 380 - 382
  • [48] BINDING OF LEUKEMIC BLASTS TO VARIOUS SUBPOPULATIONS OF LYMPHOKINE-ACTIVATED KILLER-CELLS
    PALUCKA, AK
    PORWIT, A
    REIZENSTEIN, P
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1993, 37 (02) : 179 - 185
  • [49] DEVELOPMENT OF A NEW CULTURE SYSTEM FOR HUMAN LYMPHOKINE-ACTIVATED KILLER-CELLS
    MURATA, M
    YANO, T
    TOGAMI, M
    YASUMOTO, K
    SUGIMACHI, K
    KIMURA, G
    NOMOTO, K
    JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 129 (01) : 89 - 95
  • [50] HIGH DEFORMABILITY AND MOTILITY OF LYMPHOKINE-ACTIVATED KILLER-CELLS INVITRO AND INVIVO
    BOUWENS, L
    NARAYANI, I
    WISSE, E
    JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 51 (03) : 214 - 219